Katharina Krepler
Katharina Krepler has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Daniel
Karl Landsteiner Institute for Retinal Research and Imaging, Vienna, Austria
2 shared publications - Alexandra Graf
Medical University of Vienna
2 shared publications - Martin Stattin
Karl Landsteiner Institute for Retinal Research and Imaging, Vienna, Austria
2 shared publications - Siamak Ansari-Shahrezaei
Karl Landsteiner Institute for Retinal Research and Imaging, Vienna, Austria
2 shared publications - Anna-Maria Haas
Karl Landsteiner Institute for Retinal Research and Imaging, Vienna, Austria
1 shared publication B Wimpissinger
1 shared publication
Latest Publications
- Open Access
- 25 September 2020
- Published by Springer Nature in BMC Ophthalmology
- Vol. 20 (1) , 1-7
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Background: Type 2 macular neovascularization (MNV) is supposed to be a rare condition in age-related macular degeneration (AMD). The main purpose of this study was to assess accompanying factors of type 2 MNV in AMD. Methods: Retrospective data analysis of eyes previously diagnosed with neovascular AMD in a tertiary eye care center (Medical Retina Unit, Rudolf Foundation Hospital, Vienna, Austria) between June 2008 and December 2017. Drusen subtypes, fibrosis, atrophy and subfoveal choroidal thickness (SFCT) of both eyes in patients with type 2 MNV lesions were categorized based on multimodal imaging. Results: Type 2 MNV was diagnosed in 27 (3.2%) of 835 eyes (749 patients). Drusen characteristics in type 2 MNV were observed as followed: drusen < 63 μm in 2 eyes (7.4%), drusen ≥63 μm in 10 eyes (37%), subretinal drusenoid deposits (SDD) in 8 eyes (29.6%), cuticular drusen in 2 eye (7.4%) and no drusen were evident in 10 eyes (37%). Drusen distribution in 23 fellow eyes was detected as followed: drusen < 63 μm in 2 eyes (8.7%), drusen ≥63 μm in 9 eyes (39.1%), SDD in 5 eyes (21.7%), cuticular drusen in 1 eye (4.3%) and no drusen were evident in 9 eyes (39.1%). Mean SFCT was 140 ± 49 μm in affected eyes and 152 ± 41 μm in the fellow eyes. Patients with drusen or SDD were significantly younger (mean 70.88 ± 6.85, p = 0.04) than patients without deposits (mean 77.40 ± 5.74). Conclusions: Type 2 MNV remains a rare entity in AMD. It was frequently seen in the absence of drusen, a hallmark of AMD. These findings contribute to the heterogeneity of phenotypes related to pure type 2 lesions.
- 25 September 2020
- Published by Springer Nature in BMC Ophthalmology
- Vol. 20 (1) , 1-7
Open AccessDrusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Background: Type 2 macular neovascularization (MNV) is supposed to be a rare condition in age-related macular degeneration (AMD). The main purpose of this study was to assess accompanying factors of type 2 MNV in AMD. Methods: Retrospective data analysis of eyes previously diagnosed with neovascular AMD in a tertiary eye care center (Medical Retina Unit, Rudolf Foundation Hospital, Vienna, Austria) between June 2008 and December 2017. Drusen subtypes, fibrosis, atrophy and subfoveal choroidal thickness (SFCT) of both eyes in patients with type 2 MNV lesions were categorized based on multimodal imaging. Results: Type 2 MNV was diagnosed in 27 (3.2%) of 835 eyes (749 patients). Drusen characteristics in type 2 MNV were observed as followed: drusen < 63 μm in 2 eyes (7.4%), drusen ≥63 μm in 10 eyes (37%), subretinal drusenoid deposits (SDD) in 8 eyes (29.6%), cuticular drusen in 2 eye (7.4%) and no drusen were evident in 10 eyes (37%). Drusen distribution in 23 fellow eyes was detected as followed: drusen < 63 μm in 2 eyes (8.7%), drusen ≥63 μm in 9 eyes (39.1%), SDD in 5 eyes (21.7%), cuticular drusen in 1 eye (4.3%) and no drusen were evident in 9 eyes (39.1%). Mean SFCT was 140 ± 49 μm in affected eyes and 152 ± 41 μm in the fellow eyes. Patients with drusen or SDD were significantly younger (mean 70.88 ± 6.85, p = 0.04) than patients without deposits (mean 77.40 ± 5.74). Conclusions: Type 2 MNV remains a rare entity in AMD. It was frequently seen in the absence of drusen, a hallmark of AMD. These findings contribute to the heterogeneity of phenotypes related to pure type 2 lesions.
- Open Access
- 9 July 2019
- Published by Hindawi Limited in Journal of Ophthalmology
- Vol. 2019, 1-8
Relationship between Neovascular Density in Swept Source-Optical Coherence Tomography Angiography and Signs of Activity in Exudative Age-Related Macular Degeneration
Purpose. To assess the relationship between signs of activity in exudative neovascular age-related macular degeneration (nAMD) following anti-vascular endothelial growth factor (anti-VEGF) treatment and morphology of choroidal neovascularization (CNV) based on neovascular density as imaged using swept source-optical coherence tomography angiography (SS-OCTA) in a qualitative manner. Methods. A single-cohort retrospective data analysis from one tertiary eye care center. Seventy-seven eyes of 72 patients were included and their charts reviewed which had been started on intravitreal injections with anti-VEGF for nAMD at least one year prior to enrollment. Clinically active disease was evaluated by slit-lamp fundus examination and spectral domain-OCT B-scans. Morphological appearance in SS-OCTA was characterized based on 5 different criteria and subsequently divided into 3 groups: predominantly hyperdense, minimally hyperdense, and hypodense lesions. Results. Fifty-eight eyes (75%) were considered clinically active and 19 eyes (25%) clinically inactive. CNV was depicted in 71 eyes (92%) by SS-OCTA and separated accordingly into predominantly hyperdense (32%), minimally hyperdense (34%), and hypodense lesions (34%). A borderline significant difference in the probability of neovascular activity for predominantly hyperdense lesions compared to hypodense lesions was detected (). Conclusions. Hyperdense choroidal neovascularization based on qualitative assessment of flow density showed a significant relation to active disease. Inactivity could not be matched adequately. This study demonstrated the potential usefulness of SS-OCTA for guidance of treatment in age-related macular degeneration.- 9 July 2019
- Published by Hindawi Limited in Journal of Ophthalmology
- Vol. 2019, 1-8
Open AccessRelationship between Neovascular Density in Swept Source-Optical Coherence Tomography Angiography and Signs of Activity in Exudative Age-Related Macular Degeneration
Purpose. To assess the relationship between signs of activity in exudative neovascular age-related macular degeneration (nAMD) following anti-vascular endothelial growth factor (anti-VEGF) treatment and morphology of choroidal neovascularization (CNV) based on neovascular density as imaged using swept source-optical coherence tomography angiography (SS-OCTA) in a qualitative manner. Methods. A single-cohort retrospective data analysis from one tertiary eye care center. Seventy-seven eyes of 72 patients were included and their charts reviewed which had been started on intravitreal injections with anti-VEGF for nAMD at least one year prior to enrollment. Clinically active disease was evaluated by slit-lamp fundus examination and spectral domain-OCT B-scans. Morphological appearance in SS-OCTA was characterized based on 5 different criteria and subsequently divided into 3 groups: predominantly hyperdense, minimally hyperdense, and hypodense lesions. Results. Fifty-eight eyes (75%) were considered clinically active and 19 eyes (25%) clinically inactive. CNV was depicted in 71 eyes (92%) by SS-OCTA and separated accordingly into predominantly hyperdense (32%), minimally hyperdense (34%), and hypodense lesions (34%). A borderline significant difference in the probability of neovascular activity for predominantly hyperdense lesions compared to hypodense lesions was detected (). Conclusions. Hyperdense choroidal neovascularization based on qualitative assessment of flow density showed a significant relation to active disease. Inactivity could not be matched adequately. This study demonstrated the potential usefulness of SS-OCTA for guidance of treatment in age-related macular degeneration. - 28 May 2019
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 257 (8) , 1649-1659
Dynamic intraoperative optical coherence tomography for inverted internal limiting membrane flap technique in large macular hole surgery
To assess the efficacy of dynamic intraoperative spectral-domain optical coherence tomography (iSD-OCT) imaging for inverted internal limiting membrane (ILM) flap technique (IILMFT) in large macular hole (MH) surgery.
- 28 May 2019
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 257 (8) , 1649-1659
Dynamic intraoperative optical coherence tomography for inverted internal limiting membrane flap technique in large macular hole surgery
To assess the efficacy of dynamic intraoperative spectral-domain optical coherence tomography (iSD-OCT) imaging for inverted internal limiting membrane (ILM) flap technique (IILMFT) in large macular hole (MH) surgery.
- 25 November 2009
- Published by BMJ in British Journal of Ophthalmology
- Vol. 93 (12) , 1695
Authors' response
For analysis of postoperative pain, we used a simplified verbal rating scale (ranging from 0, meaning no pain, to 3, meaning severe pain). The standardised verbal rating scale ranges from 0 (no pain) to 10 (“the worst pain possible”), which we think is too extensive for our patients and purpose.
- 25 November 2009
- Published by BMJ in British Journal of Ophthalmology
- Vol. 93 (12) , 1695
Authors' response
For analysis of postoperative pain, we used a simplified verbal rating scale (ranging from 0, meaning no pain, to 3, meaning severe pain). The standardised verbal rating scale ranges from 0 (no pain) to 10 (“the worst pain possible”), which we think is too extensive for our patients and purpose.
- 1 August 2009
- Published by Springer Nature in Spektrum der Augenheilkunde
- Vol. 23 (4) , 236-239
Therapie von Glaskörpertrübungen – eine Übersicht
- 1 August 2009
- Published by Springer Nature in Spektrum der Augenheilkunde
- Vol. 23 (4) , 236-239
Therapie von Glaskörpertrübungen – eine Übersicht